RadNet, Inc.
RDNT
Helyezés a részvények között
#3223
RadNet, Inc. operates as a prominent healthcare services company specializing... RadNet, Inc. operates as a prominent healthcare services company specializing in outpatient diagnostic imaging across the United States. Their comprehensive offerings span a broad spectrum of advanced imaging techniques, including magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, and general diagnostic radiology, along with various specialized procedures. Beyond direct patient services, the company also plays a significant role in developing and marketing specialized computerized systems for the diagnostic imaging sector, such as picture archiving communication systems (PACS) and associated support. Furthermore, RadNet is at the forefront of integrating artificial intelligence (AI) solutions, designing and deploying AI suites to augment radiologist interpretation, particularly in mammography, and extending these AI capabilities to lung and prostate cancer diagnostics. As of December 31, 2021, its operational footprint included ownership and management of 347 centers situated across seven states: Arizona, California, Delaware, Florida, Maryland, New Jersey, and New York. Established in 1981, the company maintains its headquarters in Los Angeles, California.
Részvényárfolyam
$70.31
Piaci kapitalizáció
$5.53B
Változás (1 nap)
1.51%
Változás (1 év)
-10.36%
Ország
US
Kereskedés RadNet, Inc. (RDNT)
Kategória
Healthcare
RadNet, Inc. (RDNT) nyeresége
Nyereség ekkor: Jun 2026 TTM: $34.98M
RadNet, Inc. legfrissebb pénzügyi jelentései szerint a vállalat jelenlegi nyeresége $34.98M. 2023 évben a vállalat $38.81M nyereséget ért el, csökkenés a 2022 év nyereségéhez, amely $42.97M volt. Az ezen az oldalon megjelenített nyereség a kamatok és adók előtti eredmény, azaz EBIT.
RadNet, Inc. nyereségtörténete 2000 és 2026 között
Nyereség az év végén
| Év | Nyereség | Változtassa meg |
|---|---|---|
| 2026 (TTM) | $34.98M | -22.03% |
| 2024 | $44.86M | 15.59% |
| 2023 | $38.81M | -9.68% |
| 2022 | $42.97M | -27.02% |
| 2021 | $58.88M | -6,994.50% |
| 2020 | $-854.00K | -102.88% |
| 2019 | $29.67M | -22.99% |
| 2018 | $38.53M | 46.02% |
| 2017 | $26.39M | 112.17% |
| 2016 | $12.44M | -15.08% |
| 2015 | $14.65M | 301.01% |
| 2014 | $3.65M | -37.95% |
| 2013 | $5.89M | -380.42% |
| 2012 | $-2.10M | -171.44% |
| 2011 | $2.94M | -114.45% |
| 2010 | $-20.34M | 99.64% |
| 2009 | $-10.19M | -46.58% |
| 2008 | $-19.07M | 5.18% |
| 2007 | $-18.13M | 163.00% |
| 2006 | $-6.89M | 119.90% |
| 2005 | $-3.14M | -66.44% |
| 2004 | $-9.34M | 74.17% |
| 2003 | $-5.36M | 3.83% |
| 2002 | $-5.17M | -156.26% |
| 2001 | $9.18M | -36.69% |
| 2000 | $14.50M | 0.00% |
Hasonló cégek vagy versenytársak nyeresége
| Vállalat | Nyereség | Nyereségkülönbség | Ország |
|---|---|---|---|
| $7.61B | 21,653.05% |
US
|
|
| $4.76B | 13,513.88% |
US
|
|
| $-252.70M | -822.44% |
US
|
|
| - | - |
CN
|
|
| $1.66B | 4,639.99% |
US
|
